Isabelle Boileau - Publications

Affiliations: 
McGill University, Montreal, QC, Canada 

55 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2017 Jaworska N, Cox SM, Casey KF, Boileau I, Cherkasova M, Larcher K, Dagher A, Benkelfat C, Leyton M. Is there a relation between novelty seeking, striatal dopamine release and frontal cortical thickness? Plos One. 12: e0174219. PMID 28346539 DOI: 10.1371/Journal.Pone.0174219  0.56
2016 Kish SJ, Boileau I, Callaghan RC, Tong J. Brain dopamine neurone "damage": methamphetamine users vs. parkinson's disease ─ A critical assessment of the evidence. The European Journal of Neuroscience. PMID 27519465 DOI: 10.1111/Ejn.13363  0.48
2016 Boileau I, Payer D, Rusjan PM, Houle S, Tong J, McCluskey T, Wilson AA, Kish SJ. Heightened Dopaminergic Response to Amphetamine at the D3 Dopamine Receptor in Methamphetamine Users. Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology. PMID 27353309 DOI: 10.1038/Npp.2016.108  0.48
2016 Booij L, Welfeld K, Leyton M, Dagher A, Boileau I, Sibon I, Baker GB, Diksic M, Soucy JP, Pruessner JC, Cawley-Fiset E, Casey KF, Benkelfat C. Dopamine cross-sensitization between psychostimulant drugs and stress in healthy male volunteers. Translational Psychiatry. 6: e740. PMID 26905412 DOI: 10.1038/tp.2016.6  0.56
2016 Tong J, Fitzmaurice PS, Moszczynska A, Mattina K, Ang LC, Boileau I, Furukawa Y, Sailasuta N, Kish SJ. Do glutathione levels decline in aging human brain? Free Radical Biology & Medicine. PMID 26845616 DOI: 10.1016/J.Freeradbiomed.2016.01.029  0.48
2015 Di Ciano P, Pushparaj A, Kim A, Hatch J, Masood T, Ramzi A, Khaled MA, Boileau I, Winstanley CA, Le Foll B. The Impact of Selective Dopamine D2, D3 and D4 Ligands on the Rat Gambling Task. Plos One. 10: e0136267. PMID 26352802 DOI: 10.1371/journal.pone.0136267  0.48
2015 Zack M, Boileau I, Payer D, Chugani B, Lobo DS, Houle S, Wilson AA, Warsh JJ, Kish SJ. Differential cardiovascular and hypothalamic pituitary response to amphetamine in male pathological gamblers versus healthy controls. Journal of Psychopharmacology (Oxford, England). PMID 26152320 DOI: 10.1177/0269881115592338  0.48
2015 Boileau I, Nakajima S, Payer D. Imaging the D3 dopamine receptor across behavioral and drug addictions: Positron emission tomography studies with [(11)C]-(+)-PHNO. European Neuropsychopharmacology : the Journal of the European College of Neuropsychopharmacology. PMID 26141509 DOI: 10.1016/J.Euroneuro.2015.06.002  0.48
2015 Boileau I, Rusjan PM, Williams B, Mansouri E, Mizrahi R, De Luca V, Johnson DS, Wilson AA, Houle S, Kish SJ, Tong J. Blocking of fatty acid amide hydrolase activity with PF-04457845 in human brain: a positron emission tomography study with the novel radioligand [(11)C]CURB. Journal of Cerebral Blood Flow and Metabolism : Official Journal of the International Society of Cerebral Blood Flow and Metabolism. PMID 26082009 DOI: 10.1038/Jcbfm.2015.133  0.48
2015 Nakajima S, Caravaggio F, Boileau I, Chung JK, Plitman E, Gerretsen P, Wilson AA, Houle S, Mamo DC, Graff-Guerrero A. Lack of age-dependent decrease in dopamine D3 receptor availability: a [(11)C]-(+)-PHNO and [(11)C]-raclopride positron emission tomography study. Journal of Cerebral Blood Flow and Metabolism : Official Journal of the International Society of Cerebral Blood Flow and Metabolism. PMID 26058690 DOI: 10.1038/Jcbfm.2015.129  0.48
2015 Boileau I, Tyndale RF, Williams B, Mansouri E, Westwood DJ, Foll BL, Rusjan PM, Mizrahi R, De Luca V, Zhou Q, Wilson AA, Houle S, Kish SJ, Tong J. The fatty acid amide hydrolase C385A variant affects brain binding of the positron emission tomography tracer [(11)C]CURB. Journal of Cerebral Blood Flow and Metabolism : Official Journal of the International Society of Cerebral Blood Flow and Metabolism. PMID 26036940 DOI: 10.1038/Jcbfm.2015.119  0.48
2015 Payer DE, Guttman M, Kish SJ, Tong J, Strafella A, Zack M, Adams JR, Rusjan P, Houle S, Furukawa Y, Wilson AA, Boileau I. [¹¹C]-(+)-PHNO PET imaging of dopamine D(2/3) receptors in Parkinson's disease with impulse control disorders. Movement Disorders : Official Journal of the Movement Disorder Society. 30: 160-6. PMID 25641350 DOI: 10.1002/Mds.26135  0.48
2015 Wing VC, Payer DE, Houle S, George TP, Boileau I. Measuring cigarette smoking-induced cortical dopamine release: A [¹¹C]FLB-457 PET study. Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology. 40: 1417-27. PMID 25502631 DOI: 10.1038/Npp.2014.327  0.48
2015 Christopher L, Duff-Canning S, Koshimori Y, Segura B, Boileau I, Chen R, Lang AE, Houle S, Rusjan P, Strafella AP. Salience network and parahippocampal dopamine dysfunction in memory-impaired Parkinson disease. Annals of Neurology. 77: 269-80. PMID 25448687 DOI: 10.1002/Ana.24323  0.48
2015 Strang NM, Claus ED, Ramchandani VA, Graff-Guerrero A, Boileau I, Hendershot CS. Dose-dependent effects of intravenous alcohol administration on cerebral blood flow in young adults. Psychopharmacology. 232: 733-44. PMID 25110231 DOI: 10.1007/S00213-014-3706-Z  0.48
2015 Tong J, Ang LC, Williams B, Furukawa Y, Fitzmaurice P, Guttman M, Boileau I, Hornykiewicz O, Kish SJ. Low levels of astroglial markers in Parkinson's disease: Relationship to α-synuclein accumulation Neurobiology of Disease. 82: 243-253. DOI: 10.1016/j.nbd.2015.06.010  0.48
2014 Boileau I, Bloomfield PM, Rusjan P, Mizrahi R, Mufti A, Vitcu I, Kish SJ, Houle S, Wilson AA, Tong J. Whole-body radiation dosimetry of 11C-carbonyl-URB694: a PET tracer for fatty acid amide hydrolase. Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine. 55: 1993-7. PMID 25413137 DOI: 10.2967/Jnumed.114.146464  0.48
2014 Le Foll B, Wilson AA, Graff A, Boileau I, Di Ciano P. Recent methods for measuring dopamine D3 receptor occupancy in vivo: importance for drug development. Frontiers in Pharmacology. 5: 161. PMID 25071579 DOI: 10.3389/fphar.2014.00161  0.48
2014 Le Foll B, Collo G, Rabiner EA, Boileau I, Merlo Pich E, Sokoloff P. Dopamine D3 receptor ligands for drug addiction treatment: update on recent findings. Progress in Brain Research. 211: 255-75. PMID 24968784 DOI: 10.1016/B978-0-444-63425-2.00011-8  0.48
2014 Tong J, Fitzmaurice P, Furukawa Y, Schmunk GA, Wickham DJ, Ang LC, Sherwin A, McCluskey T, Boileau I, Kish SJ. Is brain gliosis a characteristic of chronic methamphetamine use in the human? Neurobiology of Disease. 67: 107-18. PMID 24704312 DOI: 10.1016/J.Nbd.2014.03.015  0.48
2014 Mizrahi R, Kenk M, Suridjan I, Boileau I, George TP, McKenzie K, Wilson AA, Houle S, Rusjan P. Stress-induced dopamine response in subjects at clinical high risk for schizophrenia with and without concurrent cannabis use. Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology. 39: 1479-89. PMID 24385130 DOI: 10.1038/Npp.2013.347  0.48
2014 Christopher L, Marras C, Duff-Canning S, Koshimori Y, Chen R, Boileau I, Segura B, Monchi O, Lang AE, Rusjan P, Houle S, Strafella AP. Combined insular and striatal dopamine dysfunction are associated with executive deficits in Parkinson's disease with mild cognitive impairment. Brain : a Journal of Neurology. 137: 565-75. PMID 24334314 DOI: 10.1093/Brain/Awt337  0.48
2014 Boileau I, Payer D, Chugani B, Lobo DS, Houle S, Wilson AA, Warsh J, Kish SJ, Zack M. In vivo evidence for greater amphetamine-induced dopamine release in pathological gambling: a positron emission tomography study with [(11)C]-(+)-PHNO. Molecular Psychiatry. 19: 1305-13. PMID 24322203 DOI: 10.1038/Mp.2013.163  0.48
2014 Matthews BA, Kish SJ, Xu X, Boileau I, Rusjan PM, Wilson AA, DiGiacomo D, Houle S, Meyer JH. Greater monoamine oxidase a binding in alcohol dependence. Biological Psychiatry. 75: 756-64. PMID 24269057 DOI: 10.1016/J.Biopsych.2013.10.010  0.48
2014 Payer D, Balasubramaniam G, Boileau I. What is the role of the D3 receptor in addiction? A mini review of PET studies with [(11)C]-(+)-PHNO. Progress in Neuro-Psychopharmacology & Biological Psychiatry. 52: 4-8. PMID 23999545 DOI: 10.1016/J.Pnpbp.2013.08.012  0.48
2014 Le Foll B, Guranda M, Wilson AA, Houle S, Rusjan PM, Wing VC, Zawertailo L, Busto U, Selby P, Brody AL, George TP, Boileau I. Elevation of dopamine induced by cigarette smoking: novel insights from a [11C]-+-PHNO PET study in humans. Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology. 39: 415-24. PMID 23954846 DOI: 10.1038/Npp.2013.209  0.48
2014 Payer DE, Behzadi A, Kish SJ, Houle S, Wilson AA, Rusjan PM, Tong J, Selby P, George TP, McCluskey T, Boileau I. Heightened D3 dopamine receptor levels in cocaine dependence and contributions to the addiction behavioral phenotype: a positron emission tomography study with [11C]-+-PHNO. Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology. 39: 311-8. PMID 23921256 DOI: 10.1038/Npp.2013.192  0.48
2013 Chiuccariello L, Boileau I, Guranda M, Rusjan PM, Wilson AA, Zawertailo L, Houle S, Busto U, Le Foll B. Presentation of smoking-associated cues does not elicit dopamine release after one-hour smoking abstinence: A [11C]-(+)-PHNO PET study. Plos One. 8: e60382. PMID 23555962 DOI: 10.1371/Journal.Pone.0060382  0.48
2013 Tong J, Meyer JH, Furukawa Y, Boileau I, Chang LJ, Wilson AA, Houle S, Kish SJ. Distribution of monoamine oxidase proteins in human brain: implications for brain imaging studies. Journal of Cerebral Blood Flow and Metabolism : Official Journal of the International Society of Cerebral Blood Flow and Metabolism. 33: 863-71. PMID 23403377 DOI: 10.1038/Jcbfm.2013.19  0.48
2013 Rusjan PM, Wilson AA, Mizrahi R, Boileau I, Chavez SE, Lobaugh NJ, Kish SJ, Houle S, Tong J. Mapping human brain fatty acid amide hydrolase activity with PET. Journal of Cerebral Blood Flow and Metabolism : Official Journal of the International Society of Cerebral Blood Flow and Metabolism. 33: 407-14. PMID 23211960 DOI: 10.1038/Jcbfm.2012.180  0.48
2013 Le Foll B, Boileau I. Repurposing buspirone for drug addiction treatment. The International Journal of Neuropsychopharmacology / Official Scientific Journal of the Collegium Internationale Neuropsychopharmacologicum (Cinp). 16: 251-3. PMID 23174122 DOI: 10.1017/S1461145712000995  0.48
2013 Boileau I, Payer D, Chugani B, Lobo D, Behzadi A, Rusjan PM, Houle S, Wilson AA, Warsh J, Kish SJ, Zack M. The D2/3 dopamine receptor in pathological gambling: a positron emission tomography study with [11C]-(+)-propyl-hexahydro-naphtho-oxazin and [11C]raclopride. Addiction (Abingdon, England). 108: 953-63. PMID 23167711 DOI: 10.1111/Add.12066  0.48
2012 Suridjan I, Boileau I, Bagby M, Rusjan PM, Wilson AA, Houle S, Mizrahi R. Dopamine response to psychosocial stress in humans and its relationship to individual differences in personality traits. Journal of Psychiatric Research. 46: 890-7. PMID 22475321 DOI: 10.1016/j.jpsychires.2012.03.009  0.48
2012 Payer DE, Dean AC, Boileau I. What matters in measuring methamphetamine-related cognitive impairments: 'abnormality detection' versus 'everyday import'? Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology. 37: 1081-2. PMID 22419225 DOI: 10.1038/Npp.2011.309  0.48
2012 Boileau I, Payer D, Houle S, Behzadi A, Rusjan PM, Tong J, Wilkins D, Selby P, George TP, Zack M, Furukawa Y, McCluskey T, Wilson AA, Kish SJ. Higher binding of the dopamine D3 receptor-preferring ligand [11C]-(+)-propyl-hexahydro-naphtho-oxazin in methamphetamine polydrug users: a positron emission tomography study. The Journal of Neuroscience : the Official Journal of the Society For Neuroscience. 32: 1353-9. PMID 22279219 DOI: 10.1523/Jneurosci.4371-11.2012  0.48
2012 Callaghan RC, Cunningham JK, Allebeck P, Arenovich T, Sajeev G, Remington G, Boileau I, Kish SJ. Methamphetamine use and schizophrenia: a population-based cohort study in California. The American Journal of Psychiatry. 169: 389-96. PMID 22193527 DOI: 10.1176/Appi.Ajp.2011.10070937  0.48
2012 Mizrahi R, Addington J, Rusjan PM, Suridjan I, Ng A, Boileau I, Pruessner JC, Remington G, Houle S, Wilson AA. Increased stress-induced dopamine release in psychosis. Biological Psychiatry. 71: 561-7. PMID 22133268 DOI: 10.1016/J.Biopsych.2011.10.009  0.48
2011 Tong J, Boileau I, Furukawa Y, Chang LJ, Wilson AA, Houle S, Kish SJ. Distribution of vesicular monoamine transporter 2 protein in human brain: implications for brain imaging studies. Journal of Cerebral Blood Flow and Metabolism : Official Journal of the International Society of Cerebral Blood Flow and Metabolism. 31: 2065-75. PMID 21522164 DOI: 10.1038/Jcbfm.2011.63  0.48
2010 Kish SJ, Lerch J, Furukawa Y, Tong J, McCluskey T, Wilkins D, Houle S, Meyer J, Mundo E, Wilson AA, Rusjan PM, Saint-Cyr JA, Guttman M, Collins DL, Shapiro C, ... ... Boileau I, et al. Decreased cerebral cortical serotonin transporter binding in ecstasy users: a positron emission tomography/[(11)C]DASB and structural brain imaging study. Brain : a Journal of Neurology. 133: 1779-97. PMID 20483717 DOI: 10.1093/Brain/Awq103  0.48
2010 Boileau I, Houle S, Rusjan PM, Furukawa Y, Wilkins D, Tong J, Selby P, Wilson AA, Kish SJ. Influence of a low dose of amphetamine on vesicular monoamine transporter binding: a PET (+)[11C]DTBZ study in humans. Synapse (New York, N.Y.). 64: 417-20. PMID 20169578 DOI: 10.1002/Syn.20743  0.48
2009 Boileau I, Guttman M, Rusjan P, Adams JR, Houle S, Tong J, Hornykiewicz O, Furukawa Y, Wilson AA, Kapur S, Kish SJ. Decreased binding of the D3 dopamine receptor-preferring ligand [11C]-(+)-PHNO in drug-naive Parkinson's disease. Brain : a Journal of Neurology. 132: 1366-75. PMID 19153147 DOI: 10.1093/Brain/Awn337  0.48
2009 Kish SJ, Fitzmaurice PS, Boileau I, Schmunk GA, Ang LC, Furukawa Y, Chang LJ, Wickham DJ, Sherwin A, Tong J. Brain serotonin transporter in human methamphetamine users. Psychopharmacology. 202: 649-61. PMID 18841348 DOI: 10.1007/S00213-008-1346-X  0.48
2008 Boileau I, Rusjan P, Houle S, Wilkins D, Tong J, Selby P, Guttman M, Saint-Cyr JA, Wilson AA, Kish SJ. Increased vesicular monoamine transporter binding during early abstinence in human methamphetamine users: Is VMAT2 a stable dopamine neuron biomarker? The Journal of Neuroscience : the Official Journal of the Society For Neuroscience. 28: 9850-6. PMID 18815269 DOI: 10.1523/Jneurosci.3008-08.2008  0.48
2008 Tong J, Wilson AA, Boileau I, Houle S, Kish SJ. Dopamine modulating drugs influence striatal (+)-[11C]DTBZ binding in rats: VMAT2 binding is sensitive to changes in vesicular dopamine concentration. Synapse (New York, N.Y.). 62: 873-6. PMID 18720517 DOI: 10.1002/Syn.20573  0.48
2008 Boileau I, Warsh JJ, Guttman M, Saint-Cyr JA, McCluskey T, Rusjan P, Houle S, Wilson AA, Meyer JH, Kish SJ. Elevated serotonin transporter binding in depressed patients with Parkinson's disease: a preliminary PET study with [11C]DASB. Movement Disorders : Official Journal of the Movement Disorder Society. 23: 1776-80. PMID 18661545 DOI: 10.1002/Mds.22212  0.48
2008 Soliman A, O'Driscoll GA, Pruessner J, Holahan AL, Boileau I, Gagnon D, Dagher A. Stress-induced dopamine release in humans at risk of psychosis: a [11C]raclopride PET study. Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology. 33: 2033-41. PMID 17957215 DOI: 10.1038/Sj.Npp.1301597  0.48
2007 Guttman M, Boileau I, Warsh J, Saint-Cyr JA, Ginovart N, McCluskey T, Houle S, Wilson A, Mundo E, Rusjan P, Meyer J, Kish SJ. Brain serotonin transporter binding in non-depressed patients with Parkinson's disease. European Journal of Neurology : the Official Journal of the European Federation of Neurological Societies. 14: 523-8. PMID 17437611 DOI: 10.1111/J.1468-1331.2007.01727.X  0.48
2007 Boileau I, Dagher A, Leyton M, Welfeld K, Booij L, Diksic M, Benkelfat C. Conditioned dopamine release in humans: a positron emission tomography [11C]raclopride study with amphetamine. The Journal of Neuroscience : the Official Journal of the Society For Neuroscience. 27: 3998-4003. PMID 17428975 DOI: 10.1523/Jneurosci.4370-06.2007  0.48
2006 Boileau I, Dagher A, Leyton M, Gunn RN, Baker GB, Diksic M, Benkelfat C. Modeling sensitization to stimulants in humans: an [11C]raclopride/positron emission tomography study in healthy men. Archives of General Psychiatry. 63: 1386-95. PMID 17146013 DOI: 10.1001/Archpsyc.63.12.1386  0.48
2004 Barrett SP, Boileau I, Okker J, Pihl RO, Dagher A. The hedonic response to cigarette smoking is proportional to dopamine release in the human striatum as measured by positron emission tomography and [11C]raclopride. Synapse (New York, N.Y.). 54: 65-71. PMID 15352131 DOI: 10.1002/Syn.20066  0.48
2004 Zald DH, Boileau I, El-Dearedy W, Gunn R, McGlone F, Dichter GS, Dagher A. Dopamine transmission in the human striatum during monetary reward tasks. The Journal of Neuroscience : the Official Journal of the Society For Neuroscience. 24: 4105-12. PMID 15115805 DOI: 10.1523/Jneurosci.4643-03.2004  0.48
2004 Leyton M, Dagher A, Boileau I, Casey K, Baker GB, Diksic M, Gunn R, Young SN, Benkelfat C. Decreasing amphetamine-induced dopamine release by acute phenylalanine/tyrosine depletion: A PET/[11C]raclopride study in healthy men. Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology. 29: 427-32. PMID 14583741 DOI: 10.1038/Sj.Npp.1300328  0.48
2003 Boileau I, Assaad JM, Pihl RO, Benkelfat C, Leyton M, Diksic M, Tremblay RE, Dagher A. Alcohol promotes dopamine release in the human nucleus accumbens. Synapse (New York, N.Y.). 49: 226-31. PMID 12827641 DOI: 10.1002/Syn.10226  0.48
2002 Leyton M, Boileau I, Benkelfat C, Diksic M, Baker G, Dagher A. Amphetamine-induced increases in extracellular dopamine, drug wanting, and novelty seeking: a PET/[11C]raclopride study in healthy men. Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology. 27: 1027-35. PMID 12464459 DOI: 10.1016/S0893-133X(02)00366-4  0.48
2002 Boileau I, Beauregar M, Beuter A, Breault C, Lecours AR. Optokinetic stimulation and the egocentred midsagittal plane: an fMRI study. Neuroreport. 13: 61-5. PMID 11924896 DOI: 10.1097/00001756-200201210-00017  0.48
Show low-probability matches.